Profile data is unavailable for this security.
About the company
MEDIPAL HOLDINGS CORPORATION engages in the wholesale of pharmaceutical products, cosmetics and daily miscellaneous goods. The Company operates in three segments. The Ethical Pharmaceutical Wholesale segment is involved in the wholesale of pharmaceutical products, medical equipment and test reagents, the distribution and planning of specialty drugs, the construction of medical material database and others. The Cosmetics, Daily Product and General Medicine Wholesale segment is engaged in the wholesale of cosmetics, daily miscellaneous goods and general pharmaceuticals. The Veterinary Medicine and Food Processing Raw Materials Wholesale segment is engaged in the wholesale of veterinary products, food additives and food raw materials. The Company is also involved in the provision of cleaning services, the management and operation of logistics centers, the provision of manpower dispatching services and others.
- Revenue in JPY (TTM)3.24tn
- Net income in JPY26.47bn
- Incorporated1923
- Employees12.97k
- LocationMedipal Holdings Corp2-7-15, YaesuCHUO-KU 104-8461JapanJPN
- Phone+81 335175800
- Fax+81 335175028
- Websitehttps://www.medipal.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tsumura & Co | 130.89bn | 16.68bn | 287.08bn | 3.83k | 17.16 | 1.28 | 11.46 | 2.19 | 217.97 | 217.97 | 1,710.76 | 2,922.86 | 0.4093 | 0.7252 | 2.66 | 34,173,890.00 | 5.04 | 5.13 | 6.25 | 6.19 | 55.78 | 58.02 | 12.32 | 11.69 | 2.53 | -- | 0.1806 | 33.60 | 6.19 | 3.05 | 11.38 | 4.07 | 4.01 | 0.00 |
| Hisamitsu Pharmaceutical Co Inc | 117.39bn | 11.50bn | 361.95bn | 2.77k | 30.23 | 1.36 | 22.80 | 3.08 | 140.60 | 140.60 | 1,435.28 | 3,118.64 | 0.3933 | 2.57 | 3.39 | 42,378,700.00 | 3.95 | 5.94 | 4.40 | 6.77 | 60.11 | 62.17 | 10.04 | 12.63 | 6.73 | -- | 0.0054 | 39.53 | -18.78 | -6.69 | -50.52 | -12.25 | -8.03 | 0.8601 |
| JCR Pharmaceuticals Co Ltd | 34.72bn | 7.66bn | 379.59bn | 732.00 | 47.46 | 9.30 | 39.45 | 10.93 | 61.67 | 61.67 | 279.63 | 314.85 | 0.5234 | 0.6713 | 3.98 | 47,427,600.00 | 11.54 | 8.29 | 18.57 | 10.68 | 75.79 | 69.85 | 22.05 | 15.61 | 1.16 | -- | 0.3164 | 26.88 | 21.40 | 11.52 | 157.36 | 30.96 | 39.71 | 18.13 |
| TAKARA BIO INC. | 54.42bn | 15.17bn | 386.53bn | 1.54k | 25.48 | 4.81 | 20.44 | 7.10 | 125.96 | 125.96 | 451.94 | 668.00 | 0.6282 | 1.55 | 5.53 | 35,360,620.00 | 17.56 | 5.77 | 20.25 | 6.37 | 74.07 | 61.33 | 27.96 | 11.66 | 2.71 | -- | 0.00 | 22.95 | 33.33 | 9.16 | 149.99 | 48.23 | 30.09 | 54.80 |
| Alfresa Holdings Corporation | 2.60tn | 22.03bn | 398.12bn | 12.05k | 16.28 | 0.7378 | 11.68 | 0.1533 | 104.09 | 104.09 | 12,267.73 | 2,296.01 | 1.92 | 16.15 | 4.29 | 215,586,900.00 | 1.63 | 2.64 | 4.23 | 7.25 | 6.78 | 7.33 | 0.8479 | 1.32 | 1.07 | -- | 0.0012 | 27.87 | -3.53 | 0.2069 | -39.16 | -6.87 | 5.04 | 9.94 |
| ROHTO PHARMACEUTICAL CO., LTD. | 184.96bn | 19.54bn | 410.95bn | 6.60k | 20.38 | 2.47 | 15.62 | 2.22 | 170.78 | 170.78 | 1,616.79 | 1,406.33 | 0.8428 | 2.38 | 4.61 | 28,041,390.00 | 8.92 | 6.13 | 12.00 | 8.75 | 58.86 | 59.47 | 10.58 | 6.96 | 1.82 | -- | 0.0587 | 22.70 | -3.74 | 1.65 | 8.65 | 12.97 | 16.85 | 6.96 |
| Peptidream Inc | 11.45bn | 4.33bn | 485.59bn | 128.00 | 112.15 | 21.89 | 98.76 | 42.41 | 33.30 | 33.30 | 88.90 | 170.59 | 0.5201 | 3.78 | 13.18 | 89,445,060.00 | 19.66 | -- | 21.52 | -- | 80.85 | -- | 37.81 | -- | 6.70 | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- |
| Medipal Holdings Corp | 3.24tn | 26.47bn | 527.44bn | 12.97k | 18.25 | 0.8568 | 10.32 | 0.1627 | 118.18 | 118.18 | 14,532.31 | 2,517.51 | 1.93 | 20.26 | 4.57 | 249,929,700.00 | 2.18 | 2.63 | 5.96 | 7.42 | 6.63 | 7.13 | 1.13 | 1.33 | 1.07 | -- | 0.0449 | 25.33 | -1.29 | 1.18 | -36.98 | -4.91 | -16.41 | 8.45 |
| Santen Pharmaceutical Co Ltd | 257.03bn | 8.02bn | 647.05bn | 4.23k | 80.91 | 2.07 | 26.57 | 2.52 | 19.97 | 19.97 | 642.22 | 779.36 | 0.6373 | 2.53 | 2.92 | 60,777,490.00 | 1.96 | 6.09 | 2.33 | 7.32 | 60.94 | 61.26 | 3.07 | 10.21 | 2.29 | 17.48 | 0.0959 | 44.96 | 3.33 | 5.03 | -71.10 | -33.72 | 21.23 | 2.29 |
| Nippon Shinyaku Co., Ltd. | 133.13bn | 27.21bn | 671.60bn | 2.06k | 23.67 | 3.78 | 21.92 | 5.04 | 403.96 | 403.96 | 1,976.59 | 2,526.54 | 0.7035 | 1.49 | 3.19 | 64,657,120.00 | 14.39 | 9.63 | 16.67 | 11.41 | 62.17 | 55.58 | 20.45 | 14.21 | 4.04 | -- | 0.00 | 30.43 | 4.50 | 7.68 | 22.74 | 26.70 | 4.93 | 28.73 |
Data as of Sep 24 2021. Currency figures normalised to Medipal Holdings Corp's reporting currency: Japanese Yen JPY
16.43%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Silchester International Investors LLPas of 18 May 2021 | 12.34m | 5.05% |
| Nomura Asset Management Co., Ltd.as of 15 Dec 2020 | 7.58m | 3.10% |
| The Vanguard Group, Inc.as of 03 Sep 2021 | 3.94m | 1.61% |
| Norges Bank Investment Managementas of 31 Dec 2020 | 3.38m | 1.38% |
| Daiwa Asset Management Co. Ltd.as of 31 Aug 2021 | 3.01m | 1.23% |
| Nikko Asset Management Co., Ltd.as of 02 Sep 2021 | 3.00m | 1.23% |
| BlackRock Fund Advisorsas of 02 Sep 2021 | 2.92m | 1.19% |
| Geode Capital Management LLCas of 16 Sep 2021 | 1.53m | 0.63% |
| Mitsubishi UFJ Kokusai Asset Management Co., Ltd.as of 02 Sep 2021 | 1.45m | 0.59% |
| Morant Wright Management Ltd.as of 31 Mar 2021 | 1.01m | 0.41% |
More ▼
Data from 31 Dec 2020 - 30 Jun 2021Source: FactSet Research Systems Inc.
